Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 23,484 shares at $16.47 ($387K) on 2025-01-27, disclosed to the SEC on 2025-01-28.
Scheduled sale ($387k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.47 | 11,742 | $193K | 50.0% |
| 2 | $16.47 | 11,742 | $193K | 50.0% |
| Total | $16.47 avg | 23,484 | $387K | 100% |
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |